Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (131-140 of 337) with videos related to

Pageof 34
Sort By:
Contemporary Clinical Trials|January 24, 2006
Statistical evaluation of HIV vaccines in early clinical trialsZoe Moodie, A J Rossini, Michael G Hudgens, et al.
The Journal of Infectious Diseases|July 11, 2003
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trialsPeter B Gilbert, Victor G DeGruttola, Michael G Hudgens, et al.
Biometrics|September 19, 2020
Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trialsNima S Hejazi, Mark J van der Laan, Holly E Janes, et al.
Nature Medicine|September 14, 2021
A government-led effort to identify correlates of protection for COVID-19 vaccinesRichard A Koup, Ruben O Donis, Peter B Gilbert, et al.
Nature Medicine|January 13, 2022
Publisher Correction: Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysisRichard A Koup, Ruben O Donis, Peter B Gilbert, et al.
Statistics in Medicine|February 19, 2003
Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in SenegalPeter B Gilbert, Ian W McKeague, Geoffrey Eisen, et al.
Vaccine|March 8, 2024
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trialPeter B Gilbert, Youyi Fong, Nima S Hejazi, et al.
The Journal of Infectious Diseases|July 14, 2009
Power to detect the effects of HIV vaccination in repeated low-dose challenge experimentsMichael G Hudgens, Peter B Gilbert, John R Mascola, et al.
The Journal of Infectious Diseases|June 26, 2021
Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy TrialsYing Huang, Brian D Williamson, Zoe Moodie, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2005
Prognostic significance of DCC and p27Kip1 in colorectal cancerJames T Wu, Sanjay Kakar, Richard L Nelson, et al.
Pageof 34

Showing results (131-140 of 337) with videos related to

Sort By:
Pageof 34
Contemporary Clinical Trials|January 24, 2006
Statistical evaluation of HIV vaccines in early clinical trialsZoe Moodie, A J Rossini, Michael G Hudgens, et al.
The Journal of Infectious Diseases|July 11, 2003
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trialsPeter B Gilbert, Victor G DeGruttola, Michael G Hudgens, et al.
Biometrics|September 19, 2020
Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trialsNima S Hejazi, Mark J van der Laan, Holly E Janes, et al.
Nature Medicine|September 14, 2021
A government-led effort to identify correlates of protection for COVID-19 vaccinesRichard A Koup, Ruben O Donis, Peter B Gilbert, et al.
Nature Medicine|January 13, 2022
Publisher Correction: Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysisRichard A Koup, Ruben O Donis, Peter B Gilbert, et al.
Statistics in Medicine|February 19, 2003
Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in SenegalPeter B Gilbert, Ian W McKeague, Geoffrey Eisen, et al.
Vaccine|March 8, 2024
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trialPeter B Gilbert, Youyi Fong, Nima S Hejazi, et al.
The Journal of Infectious Diseases|July 14, 2009
Power to detect the effects of HIV vaccination in repeated low-dose challenge experimentsMichael G Hudgens, Peter B Gilbert, John R Mascola, et al.
The Journal of Infectious Diseases|June 26, 2021
Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy TrialsYing Huang, Brian D Williamson, Zoe Moodie, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2005
Prognostic significance of DCC and p27Kip1 in colorectal cancerJames T Wu, Sanjay Kakar, Richard L Nelson, et al.
Pageof 34